The science behind measuring body composition When it comes to weight, Body Mass Index (BMI) alone may not tell the whole story
Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
For women, particularly in midlife and beyond, movement is medicine and muscle mass is a core foundation of longevity
Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review
The OASIS-1 trial, which studied adults with obesity and overweight taking a daily 50 mg oral semaglutide, found that participants experienced a 15.1% average reduction in body weight over 68 weeks
You may not even know exactly what youre getting or whether the dose is accurate from one administration to the next. Indeed, GLP-1 use without medical oversight heightens the risk of medication side effects, such as gallbladder disease, pancreatitis, thyroid conditions, retinopathy and nutrient deficiencies
